Evidence map›Paper›PMID 31083663›Full record

ArticlePLoS genetics2019

Sir2 suppresses transcription-mediated displacement of Mcm2-7 replicative helicases at the ribosomal DNA repeats.

Eric J Foss, Tonibelle Gatbonton-Schwager, Adam H Thiesen, Erin Taylor, Rafael Soriano, Uyen Lao, David M MacAlpine, Antonio Bedalov

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Chromatin architecture sets origin licensing capacity.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Mammalian DNA Replication Timing.Cold Spring Harbor perspectives in biology · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Sir2 takes affirmative action to ensure equal opportunity in replication origin licensing.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Eric J FossClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Tonibelle Gatbonton-SchwagerClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Adam H ThiesenClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.ORCID 0000-0001-5231-5395
Erin TaylorClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Rafael SorianoClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.ORCID 0000-0002-3692-1077
Uyen LaoClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
David M MacAlpineDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, United States of America.ORCID 0000-0003-3338-8112
Antonio BedalovClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.ORCID 0000-0002-7373-8255
Fred Hutch Cancer Center · USDuke University · USUniversity of Washington · US

Funding

Chromosome Metabolism and Cancer Training GrantT32CA009657 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI EISENMAN, ROBERT NEIL · 1991 to 2020
$7.6M
Origin firing at repetitive sequences and genome replication - Admin SupplementR01GM117446 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDALOV, ANTONIO · 2016 to 2023
$4.3M
Chromatin-mediated mechanisms of genome integrityR35GM127062 · NIGMS · DUKE UNIVERSITY · PI David M MacAlpine · 2018 to 2026
$3.7M
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
NCI NIH HHS T32 CA009657NIGMS NIH HHS R01 GM117446NIGMS NIH HHS R35 GM127062NIH HHS S10 OD018164
6 · The paper itself

Abstract

Repetitive DNA sequences within eukaryotic heterochromatin are poorly transcribed and replicate late in S-phase. In Saccharomyces cerevisiae, the histone deacetylase Sir2 is required for both transcriptional silencing and late replication at the repetitive ribosomal DNA arrays (rDNA). Despite the widespread association between transcription and replication timing, it remains unclear how transcription might impinge on replication, or vice versa. Here we show that, when silencing of an RNA polymerase II (RNA Pol II)-transcribed non-coding RNA at the rDNA is disrupted by SIR2 deletion, RNA polymerase pushes and thereby relocalizes replicative Mcm2-7 helicases away from their loading sites to an adjacent region with low nucleosome occupancy, and this relocalization is associated with increased rDNA origin efficiency. Our results suggest a model in which two of the major defining features of heterochromatin, transcriptional silencing and late replication, are mechanistically linked through suppression of polymerase-mediated displacement of replication initiation complexes.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsDNA ReplicationDNA, RibosomalGene Expression Regulation, FungalGene SilencingMinichromosome Maintenance ProteinsRNA Polymerase IRNA Polymerase IISaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSilent Information Regulator Proteins, Saccharomyces cerevisiaeSirtuin 2Transcription, GeneticCell Cycle ProteinsDNA-Binding ProteinsDNA, RibosomalMinichromosome Maintenance ProteinsRNA Polymerase IRNA Polymerase IISaccharomyces cerevisiae ProteinsSilent Information Regulator Proteins, Saccharomyces cerevisiaeSIR2 protein, S cerevisiaeSirtuin 2

Identifiers

PMID31083663
PMCPMC6532929
OpenAlexW2945352929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.